ArticleInternational journal of molecular sciences2025
Human miRNAs in Cancer: Statistical Trends and Cross Kingdom Approach.
Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on the mechanism, diagnosis, and treatment of exosomal miRNA in chronic prostatitis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally and are frequently dysregulated in cancer. While most studies focus on individual miRNAs, global patterns and their potential cross-kingdom similarities remain underexplored. This study aims to identify statistically stable human miRNAs in cancer, their key target genes, and analyze sequence complementarity with plant miRNAs to highlight patterns for future research. Experimentally validated human miRNA-gene interactions from miRTarBase were integrated with TCGA expression data across multiple cancers. Using a nonlinear threshold (critical threshold III), 115 underexpressed and 93 overexpressed miRNAs were identified as regulators of 200 genes with the strongest dysregulation. Further, 10,898 plant miRNAs from 127 species were computationally compared to these human miRNAs, and average complementarity scores were calculated to identify plant miRNAs most similar to under- or overexpressed human miRNAs. Statistical parameters such as membership ratios and experiment counts quantified miRNA expression stability. Subsets of human miRNAs exhibited consistent over- or underexpression across cancers, with concordant target gene expression patterns. Several plant miRNAs showed higher complementarity to underexpressed human miRNAs, suggesting reproducible cross-kingdom sequence similarity patterns. Differences in complementarity were modest but systematic, providing a computational framework for prioritizing candidate miRNAs for further study. This work establishes a computational approach integrating human miRNA-gene interactions, cancer expression data, and plant miRNA sequences. It identifies statistically stable miRNAs, key target genes, and cross-kingdom sequence similarities without implying functional or therapeutic activity. The framework can guide future experimental studies in miRNA regulation, comparative genomics, and molecular evolution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.